A Proof-of-concept Study to Reduce Treatment Burden in Haemophilia Participants Receiving Factor VIII and Factor IX Infusions

NCT05437211 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia

Interventions

DEVICE: Virtual-reality (VR) Based Solution

Sponsor

Takeda